Selective G Protein Coupling by C-C Chemokine Receptors (*)

  1. Yanan Kuang(2),
  2. Yanping Wu(1),
  3. Huiping Jiang(1) and
  4. Dianqing Wu(1)(3)(§)
  1. From the (1)Departments of Pharmacology and Physiology,
  2. (2)Biochemistry, and
  3. (3)Oncology, University of Rochester, Rochester, New York 14642
  1. § To whom correspondence should be addressed. Tel.: 716-275-2029; Fax: 716-244-9283.

Abstract

The C-C chemokines are major mediators of chemotaxis of monocytes and some T cells in inflammatory reactions. The pathways by which the C-C chemokine receptors activate phospholipase C (PLC) were investigated in cotransfected COS-7 cells. The C-C chemokine receptor-1 (CKR-1), the MCP-1 receptor-A (MCP-1Ra), and MCP-1Rb can reconstitute ligand-induced accumulation of inositol phosphates with PLC β2 in a pertussis toxin-sensitive manner, presumably through GβGraphic released from the GGraphic proteins. However, these three receptors demonstrated different specificity in coupling to the α subunits of the GGraphic class. While none of the receptors can couple to Gαq/11, MCP-1Rb can couple to both Gα14 and Gα16, but its splicing variant, MCP-1Rb, cannot. Since MCP-1Ra and -b differ only in their C-terminal intracellular domains, the C-terminal ends of MCP-1Rs determine G protein coupling specificity. CKR-1 can couple to Gα14 but not to Gα16, suggesting some of the C-C chemokine receptors, unlike the C-X-C chemokine receptors, discriminate against Gα16, a hematopoietic-specific Gα subunit. The intriguing specificity in coupling of the GGraphic class of G proteins implies that the chemokines may be involved in some distinct functions in vivo. The commonality of the chemokine receptors in coupling to the GGraphic-GβGraphic-PLC β2 pathway provides a potential target for developing broad spectrum anti-inflammatory drugs.

Footnotes

  • * This work was supported by the Pharmaceutical Research and Manufacturers Foundation of America, Inc. and a National Institutes of Health Grant GM53162R29 (to D. W.), by the Leukemia Society of America, and by Grant IRG-18 from the American Cancer Society (to H. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • 1 The abbreviations used are:

    IL

    interleukin

    MCP

    macrophage chemotactic protein

    RANTES

    regulated upon activation, normal T cell expressed and secreted

    MIP

    macrophage inflammatory protein

    PLC

    phospholipase C

    IP

    inositol phosphate

    PTX

    pertussis toxin.

    • Received September 18, 1995.
    • Revision received December 27, 1995.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement